EXAGEN INC. - COMMON S

Exagen Announces New Rheumatoid Arthritis Scientific Advisory Board

16 мар 2022 15:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2022 KeyBanc Capital Markets Life Sciences and MedTech Investor Forum

09 мар 2022 15:05:00 Источник Nasdaq GlobeNewswire

Exagen to Announce Fourth Quarter and Full Year Financial Results on March 22, 2022

08 мар 2022 15:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2022 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

02 фев 2022 15:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. and Queen Mary University of London Announce Exclusive License and Collaboration to Develop Novel Patented Molecular Signatures for Rheumatoid Arthritis Biologic Therapeutic Selection

09 янв 2022 11:00:00 Источник Nasdaq GlobeNewswire

Exagen Inc. to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

17 ноя 2021 15:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. Reports Third Quarter 2021 Results

10 ноя 2021 15:05:01 Источник Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum

04 ноя 2021 15:05:01 Источник Nasdaq GlobeNewswire

Exagen to Announce Third Quarter 2021 Financial Results on November 10, 2021

27 окт 2021 15:05:01 Источник Nasdaq GlobeNewswire

Exagen Inc. Expands Coverage with Inland Empire Health Plan, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE Lupus

27 окт 2021 07:25:00 Источник Nasdaq GlobeNewswire

Exagen Inc. Announces $27.2 Million Debt Refinancing

25 окт 2021 07:25:00 Источник Nasdaq GlobeNewswire

Exagen Showcases Eight Scientific Presentations at ACR’s Virtual Annual Meeting in November 2021

21 окт 2021 15:05:00 Источник Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference

13 сен 2021 15:15:00 Источник Nasdaq GlobeNewswire

Exagen Inc. Reports Second Quarter 2021 Results

09 авг 2021 15:05:01 Источник Nasdaq GlobeNewswire

Exagen Appoints Ana Hooker to Board of Directors

30 июл 2021 07:25:00 Источник Nasdaq GlobeNewswire

Exagen Inc. to Participate in the Canaccord Genuity 41st Annual Growth Conference

29 июл 2021 07:25:00 Источник Nasdaq GlobeNewswire

Exagen to Announce Second Quarter 2021 Financial Results on August 9, 2021

26 июл 2021 15:05:56 Источник Nasdaq GlobeNewswire

AVISE® Lupus Test Demonstrates Statistically Significant Clinical Utility in Achieving a Definitive SLE Diagnosis and Positively Impacts Treatment Decisions

13 июл 2021 15:05:00 Источник Nasdaq GlobeNewswire

Exagen Elects Frank Stokes to Board of Directors

18 июн 2021 07:29:00 Источник Nasdaq GlobeNewswire

Exagen Inc. to Participate in the William Blair 41st Annual Growth Stock Conference

24 май 2021 15:05:00 Источник Nasdaq GlobeNewswire